MAHA ELEVATE could open a federal funding pipeline to interventions that can't survive contact with a plausibility filter.

In December, Trump said he would summon health insurance execs to the White House. It doesn't seem a meeting ever happened.

For decades, venture capitalists have relied on a tried-and-true recipe to make money in biotech. Now that approach is being ...

In the past weeks, the international media have reported explosions in central Tehran, including in the politically sensitive ...

We can’t afford another sweeping restructuring of the food supply based on imprecise interventions and uncertain science,” ...

There's not a consistent theme among the 10 highest and lowest spending metros, which highlights the “irrationality” of U.S.

A mother's persistence helps revive an all-but-abandoned drug class and could aid her son and thousands of others with ...

WASHINGTON — An influential progressive think tank is proposing that Democrats assert more federal government control over ...

Changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs — and whether the ...

Ubl led PhRMA through the pandemic and a slew of efforts to rein in drug prices from Democrats and Republicans.

Behind closed doors, health insurers and hospitals agree that AI scribes are bumping up health care costs. But, they don't ...

The U.S. Food and Drug Administration is seeking new powers to hold companies accountable for misleading direct-to-consumer ...